Kosin Med J.  2011 Dec;26(2):179-182.

A Case of Prolonged QT Interval Association with Galantamine

Affiliations
  • 1Department of Cardiology, Wallace Memorial Baptist Hospital, Busan, Korea. jjhoon69@yahoo.co.kr
  • 2Department of Cardiology, Kosin University College of Medicine, Busan, Korea.

Abstract

Among the Acetylcholinesterase inhibitors as used for Alzheimer's disease treatment, Galantamine has been recently developed and widely used owing to proven its clinical efficacy and safety. However, it has reported that prolonged QT interval, which can lead to ventricular arrythimias such as Torsade de points, has developed in Galantamine-treated patients. A 74-year-old female Alzheimer's patient been treated with galantamine for 8 months visited the hospital complaining about frequent dizziness. ECG monitor was performed promptly, it was informed that the prolonged QTc interval was increased 450 ms to 486 ms. So, we made her stop taking the galantamine, and after that QTc interval has normalized to 406 ms. In this article, we reported the first case on prolonged QT interval associated with galantamine in Korea.

Keyword

EKG; Galantamine; Prolonged QT interval

MeSH Terms

Aged
Alzheimer Disease
Cholinesterase Inhibitors
Dizziness
Electrocardiography
Female
Galantamine
Humans
Korea
Organothiophosphorus Compounds
Cholinesterase Inhibitors
Galantamine
Organothiophosphorus Compounds
Full Text Links
  • KMJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr